Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
General Internal Medicine
•
Neurology
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
Related Questions
What is the role for inpatient limited-montage EEG recording?
What factors would prompt you to refer a patient for a surgical epilepsy evaluation who has not yet failed two anti-seizure medications?
Do you make any dose adjustments for patients with ESKD who are on apixaban and do not otherwise meet criteria for reduced dosing?
How do you interpret CSF pleocytosis in the context of significant leukocytosis on CBC?
How often do you consider lamotrigine in patients with myoclonic epilepsy?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What markers on EEG can help predict/detect postoperative or ICU-related delirium?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How do you advise patients with epilepsy that are planning pregnancy and use invasive neuromodulation for treatment of their epilepsy?
How do you manage a patient who has history consistent with juvenille myoclonic epilepsy (JME) but does not have the classic polyspike pattern on EEG?
